Supernus Pharmaceuticals (SUPN) Debt Ratio (2011 - 2025)
Supernus Pharmaceuticals (SUPN) posted quarterly Debt Ratio of 0.02 for Q4 2025, down 38.23% year-over-year from 0.03 in Q4 2024, and up 170.13% on a QoQ basis from 0.01 in Q3 2025.
Supernus Pharmaceuticals (SUPN) Debt Ratio (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals has reported Debt Ratio for 9 years, with the latest figure at 0.02 in Q4 2025.
- Debt Ratio for Q4 2025 came in at 0.02, down 38.23% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.02 (down 38.23% YoY), and the FY2025 annual result was 0.02, down 38.23% from the prior year.
- Debt Ratio advanced to 0.02 in Q4 2025, from 0.01 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.25 in Q4 2021 and troughed at 0.01 in Q3 2025.
- A 5-year average of 0.06 and a median of 0.03 in 2024 frame the typical range for Debt Ratio.
- The largest YoY upside for Debt Ratio was 1480.6% in 2022 against a maximum downside of 95.06% in 2022.
- A 5-year view of Debt Ratio shows it stood at 0.25 in 2021, then sank by 95.06% to 0.01 in 2022, then soared by 228.52% to 0.04 in 2023, then fell by 15.09% to 0.03 in 2024, then tumbled by 38.23% to 0.02 in 2025.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.02 in Q4 2025, 0.01 in Q3 2025, and 0.02 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.12 |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.03 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.25 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.02 |
| Dec 31, 2020 | 0.02 |